ES2141134T3 - Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares. - Google Patents

Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares.

Info

Publication number
ES2141134T3
ES2141134T3 ES93305682T ES93305682T ES2141134T3 ES 2141134 T3 ES2141134 T3 ES 2141134T3 ES 93305682 T ES93305682 T ES 93305682T ES 93305682 T ES93305682 T ES 93305682T ES 2141134 T3 ES2141134 T3 ES 2141134T3
Authority
ES
Spain
Prior art keywords
pirrolidone
carbamoil
depression
derivatives
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93305682T
Other languages
English (en)
Inventor
Hiromu Matsumura
Toshisada Yano
Hiroshi Hashizume
Nobuhiro Ibii
Teruo Shiomi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2141134T3 publication Critical patent/ES2141134T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UN COMPUESTO DE LA FORMULA (I): EN DONDE X1 Y X2 REPRESENTAN CADA UNO INDEPENDIENTEMENTE ALQUILO INFERIOR, ALCOXILO INFERIOR O HALOGENO O UNA SAL ACEPTABLE FARMACEUTICAMENTE DE EL, LOS CUALES SE USAN COMO UN INGREDIENTE ACTIVO PARA UNA COMPOSICION FARMACEUTICA PARA TRATAMIENTO ANTI POSTERIORES DE TRASTORNOS CEREBRO VASCULARES.
ES93305682T 1992-07-23 1993-07-20 Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares. Expired - Lifetime ES2141134T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21815292 1992-07-23

Publications (1)

Publication Number Publication Date
ES2141134T3 true ES2141134T3 (es) 2000-03-16

Family

ID=16715459

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93305682T Expired - Lifetime ES2141134T3 (es) 1992-07-23 1993-07-20 Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares.

Country Status (10)

Country Link
US (1) US5321035A (es)
EP (1) EP0580398B1 (es)
KR (1) KR100255619B1 (es)
CN (1) CN1040752C (es)
AT (1) ATE186912T1 (es)
AU (1) AU657423B2 (es)
CA (1) CA2100641A1 (es)
DE (1) DE69327077T2 (es)
ES (1) ES2141134T3 (es)
TW (1) TW275629B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3719612B2 (ja) * 1993-06-14 2005-11-24 塩野義製薬株式会社 ヘテロ環を含有する尿素誘導体
JP3546294B2 (ja) 1998-04-28 2004-07-21 トヨタ自動車株式会社 内燃機関の排気浄化装置
AU2018234001B2 (en) 2017-03-13 2022-01-06 Sumitomo Pharma Co., Ltd. 2,6-disubstituted pyridine derivative

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
US5202345A (en) * 1987-08-19 1993-04-13 Shionogi & Co., Ltd. Carbamoylpyrrolidone derivatives and drugs for senile dementia
CA1305148C (en) * 1987-08-19 1992-07-14 Hiromu Matsumura Carbamoylpyrrolidone derivatives and drugs for senile dementia
US5243051A (en) * 1990-03-05 1993-09-07 Shionigi & Co., Ltd. Tetrahydropyridine derivatives
US5149817A (en) * 1990-03-05 1992-09-22 Shionogi & Co., Ltd. Teirahydropyridine derivatives

Also Published As

Publication number Publication date
EP0580398B1 (en) 1999-11-24
CA2100641A1 (en) 1994-01-24
KR940005610A (ko) 1994-03-21
DE69327077T2 (de) 2000-07-06
EP0580398A1 (en) 1994-01-26
DE69327077D1 (de) 1999-12-30
AU4209693A (en) 1994-01-27
AU657423B2 (en) 1995-03-09
CN1040752C (zh) 1998-11-18
US5321035A (en) 1994-06-14
ATE186912T1 (de) 1999-12-15
TW275629B (es) 1996-05-11
CN1088206A (zh) 1994-06-22
KR100255619B1 (ko) 2000-05-01

Similar Documents

Publication Publication Date Title
MX9306831A (es) Nuevos compuestos heterociclicos.
NO904134D0 (no) Fremgangsmaate for fremstilling av pyrazolderivater.
MX9300579A (es) Derivados de pirazol, procedimientos para la preparacion de los mismos y a las composiciones farmaceuticas que comprenden a los mismos.
AU689304B2 (en) Quinazoline derivative
ATE226574T1 (de) 4,6-diarylpyrimidin-derivate und deren salze
ES549542A0 (es) Un procedimiento para preparar nuevos derivados de benzo- triazol- y benzoxazolamina
ATE243209T1 (de) Tetrahydro gamma-carboline
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ES2128335T3 (es) Derivados de imidazo(1,2-c)quinazolina como antihipertensivos y antidisuricos.
ES2141134T3 (es) Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares.
ES2035915T3 (es) Agentes antiarritmicos n-fenetil-aminoalquil-benzamida.
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
ES2076201T3 (es) Derivados de 3-piperidinil-indazol antihipertensivos.
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
FR2598914B1 (fr) Composition prophylactique et curative pour l'arteriosclerose
EP0919233B8 (en) Therapeutic agent for kidney diseases
ATE103490T1 (de) Derivate der p-guanidinobenzoesaeure zur behandlung der zerebrovaskulaeren kontraktion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 580398

Country of ref document: ES